3: New strategies for process development and process control

Monday, November 7, 2011: 1:00 PM-4:30 PM
Islands Ballroom G-J (Marriott Marco Island)
Stephen Van Dien
Everett Stone
1:00 PM
Development of a protease activity tool kit for the identification and characterization of native Pichia pastoris proteases
Christopher Kistler1, Jeffrey Bernstein2, Juergen Nett3, Briana Hecht4, James Park4, Rachel Bareither1 and Thomas I. Potgieter5, (1)Biologics New and Enabling Technologies, Merck & Co., Inc, Rahway, NJ, (2)Bioprocess Research and Development, Merck & Co., Rahway, NJ, (3)GlycoFi, a wholly owned subsidiary of Merck & Co Inc., Lebanon, NH, (4)Bioprocess Development, Merck & Co., Inc, Rahway, NJ, (5)Biologics New and Enabling Technologies, Merck & Co Inc., Rahway, NJ
1:30 PM
Luminescent Dissolved Oxygen Probe with Unique Capabilities
Ruby N. Ghosh1, Reza Loloee1, James Wynn2, Michael V. Guettler2 and Denise S. Rumler2, (1)Physics, Michigan State University, East Lansing, MI, (2)MBI, Lansing, MI
2:00 PM
From Protein Drug Discovery to Clinical Evaluation Completely within an Academic Setting
Everett M. Stone1, Jung-Hee Woo2, Arthur E. Frankel2 and George Georgiou3, (1)Biomedical Eng, University of Texas,, Austin, TX, (2)Cancer Research Institute, Scott & White, Temple, TX, (3)Cockrell Chair in Engineering, Depts of Chemical Eng., Biomedical Eng. and Molecular Genetics and Microbiology, University of Texas, Austin, TX
2:30 PM
3:00 PM
Enhancing bioprocess productivity through dynamic control of gene expression
Nikolaos Anesiadis1, Hideki Kobayashi2, William R. Cluett1 and Radhakrishnan Mahadevan1, (1)Chemical Engineering & Applied Chemistry, University of Toronto, Toronto, ON, Canada, (2)Extremobiosphere Research Center (XBR), Japan Agency for Marine-Earth Science and Technology (JAMSTEC), Yokosuka, Japan
See more of: Invited Oral Papers